| EDWARDS LIFESCIENCES |
| USA |
| Gesundheit |
| US28176E1082 / 936853 |
| EWL (Frankfurt) / EW (NYSE) |
| FRA:EWL, ETR:EWL, EWL:GR, NYSE:EW |
| S&P500 |
| https://www.edwards.com/ |
|
Edwards Lifesciences Corporation is a leading global structural heart innovation company focused on advancing treatments for cardiovascular disease. The company specializes in developing and providing innovative medical technologies for structural he..
>Volltext.. |
| 42697.4 Mio. EUR |
| 40120.48 Mio. EUR |
| 5540.17 Mio. EUR |
| 1677.57 Mio. EUR |
| 945.35 Mio. EUR |
| 1.62 EUR |
| 617.78 Mio. EUR |
| 2150.24 Mio. EUR |
| 1194.08 Mio. EUR |
| 2.61 |
| 6.56% |
| 13.43% |
| - |
| - |
| - |
| EDWARDS LIFESCIENCES, EDWARDS LIFE |
| 24.07.26 |
|
||||
|
||||
|